These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 27394160)
1. Experience with bisoprolol in long-QT1 and long-QT2 syndrome. Steinberg C; Padfield GJ; Al-Sabeq B; Adler A; Yeung-Lai-Wah JA; Kerr CR; Deyell MW; Andrade JG; Bennett MT; Yee R; Klein GJ; Green M; Laksman ZW; Krahn AD; Chakrabarti S J Interv Card Electrophysiol; 2016 Nov; 47(2):163-170. PubMed ID: 27394160 [TBL] [Abstract][Full Text] [Related]
2. Gene-specific effect of beta-adrenergic blockade on corrected QT interval in the long QT syndrome. Extramiana F; Maison-Blanche P; Denjoy I; De Jode P; Messali A; Labbé JP; Leenhardt A Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):399-408. PubMed ID: 23879280 [TBL] [Abstract][Full Text] [Related]
3. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Vyas H; Hejlik J; Ackerman MJ Circulation; 2006 Mar; 113(11):1385-92. PubMed ID: 16534005 [TBL] [Abstract][Full Text] [Related]
4. Effect of beta-blockers on QT dynamics in the long QT syndrome: measuring the benefit. Bennett MT; Gula LJ; Klein GJ; Skanes AC; Yee R; Leong-Sit P; Chattha I; Sy R; Jones DL; Krahn AD Europace; 2014 Dec; 16(12):1847-51. PubMed ID: 24833771 [TBL] [Abstract][Full Text] [Related]
5. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Wong JA; Gula LJ; Klein GJ; Yee R; Skanes AC; Krahn AD Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):120-5. PubMed ID: 20071715 [TBL] [Abstract][Full Text] [Related]
6. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. Bos JM; Crotti L; Rohatgi RK; Castelletti S; Dagradi F; Schwartz PJ; Ackerman MJ Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007280. PubMed ID: 31006312 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of different beta-blockers in the treatment of long QT syndrome. Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637 [TBL] [Abstract][Full Text] [Related]
8. Architectural T-Wave Analysis and Identification of On-Therapy Breakthrough Arrhythmic Risk in Type 1 and Type 2 Long-QT Syndrome. Sugrue A; Rohatgi RK; Noseworthy PA; Kremen V; Bos JM; Qiang B; Sapir Y; Attia ZI; Scott CG; Brady P; Asirvatham SJ; Friedman PA; Ackerman MJ Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29141844 [TBL] [Abstract][Full Text] [Related]
9. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. Chockalingam P; Crotti L; Girardengo G; Johnson JN; Harris KM; van der Heijden JF; Hauer RN; Beckmann BM; Spazzolini C; Rordorf R; Rydberg A; Clur SA; Fischer M; van den Heuvel F; Kääb S; Blom NA; Ackerman MJ; Schwartz PJ; Wilde AA J Am Coll Cardiol; 2012 Nov; 60(20):2092-9. PubMed ID: 23083782 [TBL] [Abstract][Full Text] [Related]
10. Ratio of late to early T-wave peak amplitude in 24-h electrocardiographic recordings as indicator of symptom history in patients with long-QT Syndrome types 1 and 2. Viitasalo M; Oikarinen L; Swan H; Glatter KA; Väänänen H; Fodstad H; Chiamvimonvat N; Kontula K; Toivonen L; Scheinman MM J Am Coll Cardiol; 2006 Jan; 47(1):112-20. PubMed ID: 16386673 [TBL] [Abstract][Full Text] [Related]
11. Effect of Left Cardiac Sympathetic Denervation on the Electromechanical Window in Patients with either Type 1 or Type 2 Long QT Syndrome: A Pilot Study. Schneider AE; Bos JM; Ackerman MJ Congenit Heart Dis; 2016 Sep; 11(5):437-443. PubMed ID: 26887900 [TBL] [Abstract][Full Text] [Related]
12. Role of bisoprolol in patients with long QT syndrome. Fazio G; Vernuccio F; Lo Re G; Grutta G; Mongiovì M Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):467-70. PubMed ID: 24047491 [TBL] [Abstract][Full Text] [Related]
13. Effect of change in posture and exercise on repolarization in patients with long QT syndrome with HERG channel mutations. Walker BD; Krahn AD; Klein GJ; Skanes AC; Yee R; Wang J; Hegele RA Can J Cardiol; 2005 Jan; 21(1):33-8. PubMed ID: 15685300 [TBL] [Abstract][Full Text] [Related]
14. Beta blockers normalize QT hysteresis in long QT syndrome. Krahn AD; Yee R; Chauhan V; Skanes AC; Wang J; Hegele RA; Klein GJ Am Heart J; 2002 Mar; 143(3):528-34. PubMed ID: 11868061 [TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients. Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis. Ahn J; Kim HJ; Choi JI; Lee KN; Shim J; Ahn HS; Kim YH PLoS One; 2017; 12(10):e0185680. PubMed ID: 29059199 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene. Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033 [TBL] [Abstract][Full Text] [Related]
18. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Ackerman MJ; Khositseth A; Tester DJ; Hejlik JB; Shen WK; Porter CB Mayo Clin Proc; 2002 May; 77(5):413-21. PubMed ID: 12004990 [TBL] [Abstract][Full Text] [Related]